Bendamustine is a chemotherapy drug primarily used in the treatment of various types of cancer, including chronic lymphocytic leukemia (CLL) and indolent B-cell non-Hodgkin lymphoma (NHL). It combines the properties of alkylating agents and purine analogs, making it effective in disrupting the DNA of cancer cells.
